JP Morgan Initiates ZS Pharma At Overweight

Analysts at JP Morgan initiated coverage on shares of ZS Pharma ZSPH with a Overweight rating. The target price for ZS Pharma is set to $43. ZS Pharma's shares gained 4.54% to close at $29.49 on Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: InitiationAnalyst RatingsJP Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!